40.10 Conclusion
Unequivocally the history of mesothelioma parallels that of asbestos exposure. The estimation that the asbestos cancer epidemic will cause 10 million deaths past and present renders the need to reach urgently a global ban on asbestos an issue of highest priority, so that the asbestos cancer epidemic will not become more devastating and will not continue indefinitely.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Britton M. The epidemiology of mesothelioma. Semin Oncol 2002;29:18.
Ware A, Price B. Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 2004;159:107.
Booth SJ, Weaver EJM. Malignant pleural mesothelioma five years after domestic exposure to blue asbestos. Lancet 1986;i:435.
Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prevent 1997;6:162.
Hansen J, de Klerk NH, Musk AW, Hobbs TMS. Environmental exposure to crocidolite and mesothelioma. Exposure-response relationships. Am J Respir Crit Care Med 1998;157:69.
Orenstein MR, Schenker MB. Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med 2000;6:371.
Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997;145:211.
LaDou J. The asbestos cancer epidemic. Environ Health Perspect 2004;l12:285.
López-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004;364:1157.
Weissmann LB, Corson JM, Neugut AI, Antman KH. Malignant mesothelioma following treatment for Hodgkin’s disease. J Clin Oncol 1996;14:2098.
Baris B, Demir AU, Shehu V, Karakoca Y, Kisacik G, Baris YI. Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. J Environ Pathol Toxicol Oncol 1996;15:183.
Huncharek M. Genetic factors in the aetiology of malignant mesothelioma. Eur J Cancer 1995;31:1741.
Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol 2002;29:2.
Abratt RP, Vorobiof DA, White N. Asbestos and mesothelioma in South Africa. Lung Cancer 2004;45S:S3.
Hughes RS. Malignant pleura mesothelioma. Am J Med Sci 2005;329:29.
Mark EJ, Yokoi T. Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure. Ann N Y Acad Sci 1991;643:196.
Wagner J, Sleggs C, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the northwestern Cape province. Br J Ind Med 1960;17:260.
Selikoff IJ, Hammond EC, Churg J. Asbestos exposure and neoplasia. JAMA 1964;188:22.
Webster I. Asbestos and malignancy. S Afr Med J 1973;47:165.
Zwi AB, Reid G, London SP, Kielkowski D, Sitas F, Becklake MR. Mesothelioma in South Africa 1976–1984: incidence and case characteristics. Int J Epidemiol 1989;18:320.
Niklinski J, Niklinska W, Chyczewski E, Laudanski J, Naumnik W, Chyczewski L, Pluygers. The epidemiology of asbestos related diseases. Lung Cancer 2004;45S:S7.
Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health 1996;86:179.
Dement JM, Brown DP, Okun A. Follow-up study of crysotile asbestos textile workers: cohort mortality and case-control analysis. Am J Ind Med 1994;26:431.
MacDonald AD, MacDonald JC. Malignant mesothelioma in North America. Cancer 1980;46:1650.
Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79;566.
ILO. Introductory report: decent work-safe work. Geneva: International Labour Organization. 2002.
Howie RM. Asbestos and cancer risk. Ann Occup Hyg 2001;45:335.
Langer AM, Nolan RP, Constantopoulos SH, Moutsopoulos HM. Association of Metsovo lung and pleural mesothelioma with exposure to tremolite-containing whitewash. Lancet 1987;i:319.
Constantopoulos SH, Malamou-Mitsi V, Goudevenos J, Papathanasiou MP, Pavlidis NA, Papadimitriou CS. High in cidence of malignant pleura mesothelioma in neighbouring villages of north-west Greece. Respiration 1987;51:266.
Constantopoulos SH, Saratzis N, Goudevenos J, Kontogiannis D, Karantanas A, Katsiotis P. Tremolite whitewashing and pleural calcifications. Chest 1987;92:709.
Constantopoulos SH, Theodorakopoulos P, Dascalopoulos G, Saratzis NA, Sideris K. Metsovo lung outside Mestovo: endemic pleural calcifications in the ophiolite belts of Greece. Chest 1991;99:1158.
Constantopoulos SH, Goudevenos J, Saratzis N, Langer AE, Selikoff IJ, Moutsopoulos HM. Metsovo lung: pleural calcifications and restrictive lung function in north-western Greece; environmental exposure to mineral fiber as etiology. Environ Res 1985;38:391.
Bazas T, Bazas B, Kitas D, Gilson JC, McDonald JC. Pleural calcification in northwest Greece [letter]. Lancet 1981;1:254.
Bazas T, Oakes D, Gilson JC, Bazas B, McDonald JC. Pleural calcification in north-west Greece. Environ Res 1985;38:239.
Papiris SA, Maniati MA, Sakellariou K, Gosios C, Kontogiannis D, Constantopoulos H. Round atelectasis and Metsovo lung. Chest 1993;103:1759.
Constantopoulos SH, Dalavanga YA, Sakellariou K, Goudevenos J, Kotoulas OB. Lymphocytic alveolitis and pleural calcifications in nonoccupational asbestos exposure: protection against neoplasia? Am Rev Respir Dis 1992;146:1565.
Sakellariou K, Malamou-Mitsi V, Haritou A, Koumpaniou C, Stachouli C, Dimoliatis ID, Constantopoulos SH. Malignant pleura mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic. Eur Respir J 1996;9:1206.
Karakoca Y, Emri S, Cangir AK, Baris YI. Environmental pleural plaques due to asbestos and fibrous zeolite exposure in Turkey. Indoor Built Environ 1997;6:100.
Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung disease due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;127:251.
Metintas S, Metintas M, Ucgun I, Oner U. Malignant mesothelioma due to environmental exposure to asbestos. Follow-up of a Turkish cohort living in a rural area. Chest 2002;122:2224.
Emri S, Demir AU. Malignant pleural mesothelioma in Turkey, 2000–2002. Lung Cancer 2004;45S:S17.
Dogan M, Emri S. Environmental health problems related to mineral dusts in Ankara and Eskisehir, Turkey. Yerbilimleri 2000;22:149.
Yazicioglu S, Ilcayto R, Balci K, Sayli BS, Yorulmaz B. Pleural calcification, pleural mesotheliomas and bronchial cancers caused by tremolite dust. Thorax 1980;35:564.
Hillerdal G, Baris YI. Radiological study of pleural changes in relation to mesothelioma in Turkey. Thorax 1983;38:443.
Baris YI. Asbestos and erionite related disease. Ankara, Turkey. Semith Ofset Mat Com 1987;8.
Metintas M, Hilllerdal H, Metintas S. Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish cohort. Eur Respir J 1999;13:523.
Baris Y, Simonato L, Artvinli M, et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibers: a 4 year study in the Cappadocian region of Turkey. Int J Cancer 1987;39:10.
Maltoni C, Minardi F, Morisi L. Pleural mesotheliomas in Spargue-Dawley rats by erionite: first experimental evidence. Environ Res 1982;29:238.
Davis JM, Bolton RE, Miller BG, Niven K. Mesothelioma dose response following intraperitoneal injection of mineral fiber. Int J Exp Pathol 1991;72:263.
Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. Erionite exposure and mesotheliomas in rats. Br J Cancer 1985;51:727.
Dumortier P, Çoplü L, Broucke I, Emri S, Selcuk T, de Maerelaer V, De Vuyst P, Baris I. Erionite bodies and fibers in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey. Occup Environ Med 2001;58:261.
Rousdy-Hamady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001;357:444.
McConnochie K, Simonato L, Mavrides P, Christofides P, Pooley FD, Wagner JC. Mesothelioma in Cyprus: the role of tremolite. Thorax 1987;42:342.
Goldberg P, Goldberg M, Marne MJ, Hirsch A, Tredaniel J. Incidence of pleural mesothelioma in New Caledonia: a 10 year survey (1978–1987). Arch Environ Hlth 1991;46:306.
Luce D, Brochard P, Quenel P, Salomon-Nekiriai C, Goldberg P, Billon-Galland MA, Goldberg M. Malignant pleural mesothelioma associated with exposure to tremolite. Lancet 1994;344:8939.
Rey F, Boutin C, Steinbauer J, Viallat JR, Alessandroni P, Jutisz P, Di Giambattista D, Billon-Galland MA, Hereng P, Dumortier P, et al. Environmental pleural plaques in an asbestos exposed population of northeast Corsica. Eur Resp J 1993;6:978.
Roviaro GC, Sartori F, Calabro F, Varoli F. The association of pleural mesothelioma and tuberculosis. Am Rev Respir Dis 1982;126:569.
Cerrano PG, Jasani B, Filiberti R, Neri M, Merlo F, De Flora S, Mutti L, Puntoni R. Simian virus 40 and malignant mesothelioma. Int J Oncol 2003;22:187.
Bass P, Schouwink H, Zoetmulder FA. Malignant pleural mesothelioma. Ann Oncol 1998;9:139.
Stanton MF, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst 1972;48:797.
Bianchi C, Brollo A, Ramani L, Bianchi T, Giarelli L. Familial mesothelioma of the pleura: a report of 40 cases. Ind Health 2004;42:235.
Sweet BH, Hilleman MR. The vacualating SV40. Proc Soc Exp Biol Med 1960;105:420.
Shein HM, Enders JF. Transformation induced by simian virus 40 in human renal cell cultures. 1. Morphology and growth characteristics. Proc Natl Acad Sci U S A 1962;48:1164.
Carbone M, Lewis AM Jr, Matthews BJ, Levine AS, Dixon K. Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas. Cancer Res 1989;49:1565.
Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142:1524.
Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol 1999;180:167.
Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000;97:10214.
Brown F, Lewis AM Jr (eds). Simian virus 40 (SV40): a possible human polyomavirus. Basel: Karger, 1998.
Shah KV. Search for SV40 in human mesothelioma. In: Brown F, Lewis AM Jr (eds) Simian Virus 40 (SV40): A Possible Human Polyomavirus. Basel: Karger, 1998:68.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Papiris, S.A., Roussos, C. (2006). Epidemiology and Etiology of Mesothelioma. In: Syrigos, K.N., Nutting, C.M., Roussos, C. (eds) Tumors of the Chest. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-31040-1_40
Download citation
DOI: https://doi.org/10.1007/3-540-31040-1_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31039-6
Online ISBN: 978-3-540-31040-2
eBook Packages: MedicineMedicine (R0)